{"transactions":[{"id":4624697,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-22T20:33:09.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":6600,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000018","document":"wk-form4_1790109186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000125839426000018/wk-form4_1790109186.xml","form_type":"4"}},{"id":4624696,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-22T20:33:09.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10274,"source":{"system":"sec-edgar","filing":"0001258394-26-000018","document":"wk-form4_1790109186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000125839426000018/wk-form4_1790109186.xml","form_type":"4"}},{"id":4624656,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-22T20:21:45.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":367600,"price":39.0555,"value":14356801.8,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.68 to $39.38, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The 367,600 Ordinary Shares disclosed in Table I of this Form 4 were held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone was deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaimed beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone was the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-397959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000119312526397959/ownership.xml","form_type":"4"}},{"id":677245,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-24T21:20:49.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":6864,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000016","document":"wk-form4_1787606446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000016/wk-form4_1787606446.xml","form_type":"4"}},{"id":677244,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-24T21:20:49.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10010,"source":{"system":"sec-edgar","filing":"0001258394-26-000016","document":"wk-form4_1787606446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000016/wk-form4_1787606446.xml","form_type":"4"}},{"id":704653,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-22T21:15:39.000Z","date":"2026-07-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":7128,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000014","document":"wk-form4_1784754937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000014/wk-form4_1784754937.xml","form_type":"4"}},{"id":704652,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-22T21:15:39.000Z","date":"2026-07-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9746,"source":{"system":"sec-edgar","filing":"0001258394-26-000014","document":"wk-form4_1784754937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000014/wk-form4_1784754937.xml","form_type":"4"}},{"id":728780,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:28:03.000Z","date":"2026-06-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":7392,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000012","document":"wk-form4_1782250080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000012/wk-form4_1782250080.xml","form_type":"4"}},{"id":728779,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:28:03.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":7656,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000012","document":"wk-form4_1782250080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000012/wk-form4_1782250080.xml","form_type":"4"}},{"id":728778,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:28:03.000Z","date":"2026-06-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9482,"source":{"system":"sec-edgar","filing":"0001258394-26-000012","document":"wk-form4_1782250080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000012/wk-form4_1782250080.xml","form_type":"4"}},{"id":728777,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:28:03.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9218,"source":{"system":"sec-edgar","filing":"0001258394-26-000012","document":"wk-form4_1782250080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000012/wk-form4_1782250080.xml","form_type":"4"}},{"id":730273,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-22T21:54:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":2711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":2711,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2711},"source":{"system":"sec-edgar","filing":"0001258394-26-000010","document":"wk-form4_1782165246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000010/wk-form4_1782165246.xml","form_type":"4"}},{"id":730272,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-22T21:54:09.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":4203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4203},"source":{"system":"sec-edgar","filing":"0001258394-26-000010","document":"wk-form4_1782165246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000010/wk-form4_1782165246.xml","form_type":"4"}},{"id":730271,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:54:09.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":4203,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8954,"source":{"system":"sec-edgar","filing":"0001258394-26-000010","document":"wk-form4_1782165246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000010/wk-form4_1782165246.xml","form_type":"4"}},{"id":747047,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:02:38.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261672/ownership.xml","form_type":"4"}},{"id":747046,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:02:38.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":119807,"source":{"system":"sec-edgar","filing":"0001193125-26-261672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261672/ownership.xml","form_type":"4"}},{"id":757986,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:02:23.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251372","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251372/ownership.xml","form_type":"4"}},{"id":802616,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-22T22:17:36.000Z","date":"2026-04-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":7920,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000008","document":"wk-form4_1776896254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000008/wk-form4_1776896254.xml","form_type":"4"}},{"id":802615,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T22:17:36.000Z","date":"2026-04-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4751,"source":{"system":"sec-edgar","filing":"0001258394-26-000008","document":"wk-form4_1776896254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000008/wk-form4_1776896254.xml","form_type":"4"}},{"id":830675,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-23T20:19:34.000Z","date":"2026-03-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":8184,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000006","document":"wk-form4_1774297172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000006/wk-form4_1774297172.xml","form_type":"4"}},{"id":830674,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T20:19:34.000Z","date":"2026-03-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4487,"source":{"system":"sec-edgar","filing":"0001258394-26-000006","document":"wk-form4_1774297172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000006/wk-form4_1774297172.xml","form_type":"4"}},{"id":887719,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-23T22:47:02.000Z","date":"2026-02-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":8448,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000004","document":"wk-form4_1771886819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000004/wk-form4_1771886819.xml","form_type":"4"}},{"id":887718,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T22:47:02.000Z","date":"2026-02-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4223,"source":{"system":"sec-edgar","filing":"0001258394-26-000004","document":"wk-form4_1771886819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000004/wk-form4_1771886819.xml","form_type":"4"}},{"id":933318,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-22T22:44:48.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":8712,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-26-000002","document":"wk-form4_1769121885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000002/wk-form4_1769121885.xml","form_type":"4"}},{"id":933317,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T22:44:48.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3959,"source":{"system":"sec-edgar","filing":"0001258394-26-000002","document":"wk-form4_1769121885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839426000002/wk-form4_1769121885.xml","form_type":"4"}},{"id":959480,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-24T00:25:50.000Z","date":"2025-12-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":8976,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-25-000010","document":"wk-form4_1766535945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000010/wk-form4_1766535945.xml","form_type":"4"}},{"id":959479,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-24T00:25:50.000Z","date":"2025-12-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3695,"source":{"system":"sec-edgar","filing":"0001258394-25-000010","document":"wk-form4_1766535945.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000010/wk-form4_1766535945.xml","form_type":"4"}},{"id":963753,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-18T21:02:38.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":77400,"price":30.2409,"value":2340645.66,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.225 to $30.25, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 367,600 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":367600,"source":{"system":"sec-edgar","filing":"0001193125-25-324780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525324780/ownership.xml","form_type":"4"}},{"id":985771,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T21:02:23.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":26.0301,"value":1301505.0,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $26.035, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 445,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":445000,"source":{"system":"sec-edgar","filing":"0001193125-25-303849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525303849/ownership.xml","form_type":"4"}},{"id":989799,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-24T23:21:52.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":9240,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":264},"source":{"system":"sec-edgar","filing":"0001258394-25-000008","document":"wk-form4_1764026509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000008/wk-form4_1764026509.xml","form_type":"4"}},{"id":989798,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T23:21:52.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3431,"source":{"system":"sec-edgar","filing":"0001258394-25-000008","document":"wk-form4_1764026509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000008/wk-form4_1764026509.xml","form_type":"4"}},{"id":1004334,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-10T21:15:35.000Z","date":"2025-11-06","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":24.1094,"value":4821880.0,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.0050 to $24.2450, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 495,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may\nbe deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":495000,"source":{"system":"sec-edgar","filing":"0001193125-25-274286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525274286/ownership.xml","form_type":"4"}},{"id":1014578,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-22T23:07:55.000Z","date":"2025-10-21","kind":"exercise","planned":false,"acquired":false,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly over the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":9504,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0001258394-25-000006","document":"wk-form4_1761174473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000006/wk-form4_1761174473.xml","form_type":"4"}},{"id":1014577,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T23:07:55.000Z","date":"2025-10-21","kind":"exercise","planned":false,"acquired":true,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3167,"source":{"system":"sec-edgar","filing":"0001258394-25-000006","document":"wk-form4_1761174473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000125839425000006/wk-form4_1761174473.xml","form_type":"4"}},{"id":1104839,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:39:16.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":4203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable for Restricted Stock Units."}],"balance_after":4203,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4203},"source":{"system":"sec-edgar","filing":"0001576280-25-000203","document":"wk-form4_1750455549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000157628025000203/wk-form4_1750455549.xml","form_type":"4"}},{"id":1104838,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T21:39:16.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":6833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier."}],"balance_after":6833,"derivative":{"exercise_price":50.57,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":6833},"source":{"system":"sec-edgar","filing":"0001576280-25-000203","document":"wk-form4_1750455549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000157628025000203/wk-form4_1750455549.xml","form_type":"4"}},{"id":1118876,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:03:37.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14492,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0000950170-25-083687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083687/ownership.xml","form_type":"4"}},{"id":1118875,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:03:37.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-25-083687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083687/ownership.xml","form_type":"4"}},{"id":1118874,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-09T20:03:37.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":9632,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":105315,"source":{"system":"sec-edgar","filing":"0000950170-25-083687","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083687/ownership.xml","form_type":"4"}},{"id":1322323,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-12-26T21:02:21.000Z","date":"2024-12-20","kind":"sale","planned":false,"acquired":false,"shares":286000,"price":22.0071,"value":6294030.6,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.82 to $22.075, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 695,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund, Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may\nbe deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary\nShares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":695000,"source":{"system":"sec-edgar","filing":"0000950170-24-140391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024140391/ownership.xml","form_type":"4"}},{"id":1368640,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-11-12T23:06:14.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":12671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly for the three-year period thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable for Restricted Stock Units."}],"balance_after":12671,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12671},"source":{"system":"sec-edgar","filing":"0001576280-24-000263","document":"wk-form4_1731452768.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000157628024000263/wk-form4_1731452768.xml","form_type":"4"}},{"id":1368639,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-12T23:06:14.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":19535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly for the three-year period thereafter."}],"balance_after":19535,"derivative":{"exercise_price":28.61,"expiration_date":"2034-11-08","underlying":"Common Stock","underlying_shares":19535},"source":{"system":"sec-edgar","filing":"0001576280-24-000263","document":"wk-form4_1731452768.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000157628024000263/wk-form4_1731452768.xml","form_type":"4"}},{"id":1472600,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-21T20:05:43.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":519000,"price":17.03,"value":8838570.0,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.16, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 981,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund, Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":981000,"source":{"system":"sec-edgar","filing":"0000950170-24-076225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024076225/ownership.xml","form_type":"4"}},{"id":1478067,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-17T12:00:50.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0000950170-24-074025","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074025/ownership.xml","form_type":"4"}},{"id":1478066,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T12:00:50.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":21108,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1595683,"source":{"system":"sec-edgar","filing":"0000950170-24-074025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074025/ownership.xml","form_type":"4"}},{"id":1485681,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-10T11:45:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9632,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-24-071072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024071072/ownership.xml","form_type":"4"}},{"id":1814240,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-08-07T20:06:50.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":false,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-23-044784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044784/doc4.xml","form_type":"4"}},{"id":1814239,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-07T20:06:50.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":true,"shares":15810,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1574575,"source":{"system":"sec-edgar","filing":"0001209191-23-044784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044784/doc4.xml","form_type":"4"}},{"id":1850668,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-20T11:35:37.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21108,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0001209191-23-038221","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123038221/doc4.xml","form_type":"4"}},{"id":2192413,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-08-08T11:21:21.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15810,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-22-044694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122044694/doc4.xml","form_type":"4"}},{"id":2230757,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-16T11:39:12.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":14479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14479},"source":{"system":"sec-edgar","filing":"0001209191-22-037249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037249/doc4.xml","form_type":"4"}},{"id":2230756,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-16T11:39:12.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":14479,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":58765,"source":{"system":"sec-edgar","filing":"0001209191-22-037249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037249/doc4.xml","form_type":"4"}},{"id":2667206,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-16T12:20:00.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":14479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14479,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14479},"source":{"system":"sec-edgar","filing":"0001209191-21-040811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121040811/doc4.xml","form_type":"4"}},{"id":2674694,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-10T11:43:40.000Z","date":"2021-06-09","kind":"exercise","acquired":false,"shares":12668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12668},"source":{"system":"sec-edgar","filing":"0001209191-21-039372","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039372/doc4.xml","form_type":"4"}},{"id":2674693,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-10T11:43:40.000Z","date":"2021-06-09","kind":"exercise","acquired":true,"shares":12668,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":44286,"source":{"system":"sec-edgar","filing":"0001209191-21-039372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039372/doc4.xml","form_type":"4"}},{"id":2678400,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-08T11:29:12.000Z","date":"2021-06-05","kind":"exercise","acquired":false,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-21-038816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038816/doc4.xml","form_type":"4"}},{"id":2678399,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-08T11:29:12.000Z","date":"2021-06-05","kind":"exercise","acquired":true,"shares":6041,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":31618,"source":{"system":"sec-edgar","filing":"0001209191-21-038816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038816/doc4.xml","form_type":"4"}},{"id":3012857,"issuer":{"id":146146,"kind":"organization","name":"Avanti Acquisition Corp.","symbol":"AVAN"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Units, consisting of Class A ordinary share and one-half of","published_at":"2020-10-05T21:09:32.000Z","date":"2020-10-01","kind":"purchase","acquired":true,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The units disclosed in Table I were purchased in the Issuer's initial public offering. Such units of this Form 4 are held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd. (the \"Funds\"). Bridger Management, LLC is the investment adviser to the Funds and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the units held of record by the Funds. Mr. Mignone disclaims beneficial ownership of the units held of record by the Funds except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the units held of record by the Funds for purposes of Section 16, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The units disclosed in Table I were purchased in the Issuer's initial public offering. Such units of this Form 4 are held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd. (the \"Funds\"). Bridger Management, LLC is the investment adviser to the Funds and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the units held of record by the Funds. Mr. Mignone disclaims beneficial ownership of the units held of record by the Funds except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the units held of record by the Funds for purposes of Section 16, or for any other purpose."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0000899243-20-027310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000089924320027310/doc4.xml","form_type":"4"}},{"id":3059348,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-08-13T20:13:38.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":7956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7956},"source":{"system":"sec-edgar","filing":"0001209191-20-046593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046593/doc4.xml","form_type":"4"}},{"id":3059347,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-13T20:13:38.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":7956,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":25577,"source":{"system":"sec-edgar","filing":"0001209191-20-046593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046593/doc4.xml","form_type":"4"}},{"id":3111167,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-15T11:35:00.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":17621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17621},"source":{"system":"sec-edgar","filing":"0001209191-20-036499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036499/doc4.xml","form_type":"4"}},{"id":3111166,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-15T11:35:00.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":17621,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":17621,"source":{"system":"sec-edgar","filing":"0001209191-20-036499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036499/doc4.xml","form_type":"4"}},{"id":3114019,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-11T11:13:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":12668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":12668,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12668},"source":{"system":"sec-edgar","filing":"0001209191-20-035785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120035785/doc4.xml","form_type":"4"}},{"id":3491989,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-06-13T10:26:58.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":17621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17621,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17621},"source":{"system":"sec-edgar","filing":"0001209191-19-036590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119036590/doc4.xml","form_type":"4"}},{"id":3902676,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2018-06-07T10:46:46.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6041,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-18-036197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118036197/doc4.xml","form_type":"4"}},{"id":3937981,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-11T20:15:21.000Z","date":"2018-05-10","kind":"purchase","acquired":true,"shares":250000,"price":19.3188,"value":4829700.0,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Ordinary Shares were purchased in multiple transactions at prices ranging from $19.2450 to $19.3700, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of Ordinary Shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 1,500,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd.  (the \"Funds\"). Bridger Management, LLC is the investment adviser to the Funds and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own  the Ordinary Shares  held of record by the Funds. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Funds except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Funds for purposes of Section 16, or for any other purpose."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001209191-18-029534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118029534/doc4.xml","form_type":"4"}},{"id":3937980,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-11T20:15:21.000Z","date":"2018-05-09","kind":"purchase","acquired":true,"shares":500000,"price":19.2063,"value":9603150.0,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Ordinary Shares were purchased in multiple transactions at prices ranging from $18.99 to $19.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of Ordinary Shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The 1,500,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd.  (the \"Funds\"). Bridger Management, LLC is the investment adviser to the Funds and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own  the Ordinary Shares  held of record by the Funds. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Funds except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Funds for purposes of Section 16, or for any other purpose."}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001209191-18-029534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118029534/doc4.xml","form_type":"4"}},{"id":4555380,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":103440,"kind":"organization","name":"BRIDGER MANAGEMENT, LLC","position":1,"cik":"0001166309","reported_name":"BRIDGER MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":2,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.0001 par value per share","published_at":"2016-11-15T19:29:43.000Z","date":"2016-11-11","kind":"purchase","acquired":false,"shares":322472,"price":3.08,"value":993213.76,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest whole cent. These Shares (as defined below) were sold in multiple transactions at prices ranging from $3.00 to $3.38, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares of Common Stock, $.0001 par value per share (the \"Shares\"), reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd.  Bridger Management LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the manager of Bridger Management, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent  of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any  entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of Common Stock, $.0001 par value per share (the \"Shares\"), reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd.  Bridger Management LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the manager of Bridger Management, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent  of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any  entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose."}],"balance_after":2968115,"source":{"system":"sec-edgar","filing":"0001140361-16-086749","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166309/000114036116086749/doc1.xml","form_type":"4"}}]}